Natalie Jobe, APRN
Nurse Practitioner · Fayetteville, ARNPI 1700384716
Payments from drug & device makers
Across 21 payments — averaging $66.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Amgen$67
- Vertex$46
- Neurocrine Biosciences, Inc.$39
- Zimmer Biomet$33
- Baxter Healthcare$31
- plus $123 from 6 others
What the payments were for
- Travel & lodging$82359%
- Food & beverage$56641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $1,051 |
| Amgen(2 entities) | 3 | $67 |
| Vertex | 2 | $46 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Zimmer Biomet | 2 | $33 |
| Baxter Healthcare | 1 | $31 |
| Corium, LLC | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| AbbVie | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
| Organon | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$984
How this compares
$1,389 in reported general payments places this provider in the 75th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tresiba Flextouch U-200Insulin Degludec | 19 | $17,854 |
| JardianceEmpagliflozin | 14 | $11,992 |
| FarxigaDapagliflozin Propanediol | 15 | $7,968 |
| DapagliflozinDapagliflozin Propanediol | 17 | $7,649 |
| XareltoRivaroxaban | 12 | $6,021 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,468 |
| Eszopiclone | 11 | $1,521 |
| Omega-3 Acid Ethyl Esters | 15 | $1,195 |
| Gabapentin | 87 | $981 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $713 |
| Lisinopril | 115 | $525 |
| Omeprazole | 47 | $520 |
| Atorvastatin Calcium | 113 | $457 |
| Famotidine | 22 | $355 |
| Hydroxyzine Pamoate | 15 | $320 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fayetteville
- Elizabeth BurnsFayetteville$9K
- Heather HutchisonFayetteville$6K
- Taylor MarshallFayetteville$6K
- Merideth HanksRogers$157K
- Angela JonesJonesboro$90K
- Tiffany McConathyHot Springs$54K
- Brenna FitzgeraldNorth Little Rock$46K
- Iris KennedyLittle Rock$22K
- Virginia LaliberteHot Springs$21K
- Julia PonderLittle Rock$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.